A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese Subjects
NCT00134199
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
282
Enrollment
INDUSTRY
Sponsor class
Conditions
Obesity
Interventions
DRUG:
CP-945,598
DRUG:
sibutramine
Sponsor
Pfizer